Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

"Structural and kinetic analysis of the bacterial tranlocase-1, MraY from MRSA."

EF 2013-14

Résumé
The overuse of antibiotics has resulted in the emergence of numerous drug resistant strains of bacteria that infect human beings, including the so called ""Super Bugs"" such as methicillin-resistant Staphylococcus aureus (MRSA). MRSA is associated with a number of blood and tissue infections and in severe cases can lead to inflammation of the heart and bone marrow, or even death. While MRSA infections have traditionally been acquired in a clinical setting, there has been a dramatic increase in the number infections acquired in the community. Since 1999, the prevalence of MRSA has increased seven fold and now represents 1 in 5 samples of S. aureus that are processed in BC labs. This trend of increasing resistance in bacteria is not confined to MRSA, but is observed in several other common species of bacteria that infect humans. Treatment of these antibiotic strains of bacteria is challenging both from a clinical and an economic standpoint, with the cost of treating and controlling MRSA infections alone estimated into the hundreds of millions of dollars annually. If the observed trend of increasing resistance continues, this cost will most certainly rise. The alarming increase in antibiotic resistant bacteria is a major threat to human health and underscores the need for the development of novel antibiotics. Bacteria are protected by a structure called the cell wall, which provides a strong yet flexible barrier against host forces during infections. Disrupting the proper assembly of the cell wall results in rapid cell death. Several important antibiotics, including penicillin and vancomycin, interfere with a bacterium's ability to properly assemble the cell wall. The cell wall is primarily composed of peptidoglycan: a mesh-like material made up of special sugar molecules that are attached to small pieces of protein called peptides. The overall mesh-like structure of peptidoglycan is created by linking together individual sugar molecules through their peptide pieces. The linking together of individual molecules to create the cell wall is a multi-step process mediated by a number of proteins, and antibiotics such as penicillin and vancomycin disrupt the process by binding to the proteins involved, rendering them useless. Antibiotic resistant strains of bacteria possess mutant forms of the proteins involved in cell wall assembly to which these drugs cannot bind. In order to effectively treat infections with MRSA and other antibiotic resistant bacteria, we must develop drugs that target new bacterial proteins. This research proposal aims to approach the problem of identifying new targets and developing new drugs by determining the three dimensional structure of proteins involved in cell wall assembly. Three dimensional structures of proteins can be, and have been, used to design new drugs by acting as a guide for the design of chemical structures that will bind to proteins and put a stop to their function. By determining the structure of a protein essential to cell wall assembly in MRSA (and other bacteria that infect humans) called MraY, and by working with the Centre for Drug Research and Development (CDRD), we aim to identify and test chemical compounds that could act as new treatment options for antibiotic resistant bacterial infections.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311808
Name
Workman Sean D
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
"Structural and kinetic analysis of the bacterial tranlocase-1, MraY from MRSA."
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Biophysical; Crystallography; Mrsa; Mutagenesis; Peptidoglycan; Purification; Resistance; Structural; Translocase
Abstract
The overuse of antibiotics has resulted in the emergence of numerous drug resistant strains of bacteria that infect human beings, including the so called ""Super Bugs"" such as methicillin-resistant Staphylococcus aureus (MRSA). MRSA is associated with a number of blood and tissue infections and in severe cases can lead to inflammation of the heart and bone marrow, or even death. While MRSA infections have traditionally been acquired in a clinical setting, there has been a dramatic increase in the number infections acquired in the community. Since 1999, the prevalence of MRSA has increased seven fold and now represents 1 in 5 samples of S. aureus that are processed in BC labs. This trend of increasing resistance in bacteria is not confined to MRSA, but is observed in several other common species of bacteria that infect humans. Treatment of these antibiotic strains of bacteria is challenging both from a clinical and an economic standpoint, with the cost of treating and controlling MRSA infections alone estimated into the hundreds of millions of dollars annually. If the observed trend of increasing resistance continues, this cost will most certainly rise. The alarming increase in antibiotic resistant bacteria is a major threat to human health and underscores the need for the development of novel antibiotics. Bacteria are protected by a structure called the cell wall, which provides a strong yet flexible barrier against host forces during infections. Disrupting the proper assembly of the cell wall results in rapid cell death. Several important antibiotics, including penicillin and vancomycin, interfere with a bacterium's ability to properly assemble the cell wall. The cell wall is primarily composed of peptidoglycan: a mesh-like material made up of special sugar molecules that are attached to small pieces of protein called peptides. The overall mesh-like structure of peptidoglycan is created by linking together individual sugar molecules through their peptide pieces. The linking together of individual molecules to create the cell wall is a multi-step process mediated by a number of proteins, and antibiotics such as penicillin and vancomycin disrupt the process by binding to the proteins involved, rendering them useless. Antibiotic resistant strains of bacteria possess mutant forms of the proteins involved in cell wall assembly to which these drugs cannot bind. In order to effectively treat infections with MRSA and other antibiotic resistant bacteria, we must develop drugs that target new bacterial proteins. This research proposal aims to approach the problem of identifying new targets and developing new drugs by determining the three dimensional structure of proteins involved in cell wall assembly. Three dimensional structures of proteins can be, and have been, used to design new drugs by acting as a guide for the design of chemical structures that will bind to proteins and put a stop to their function. By determining the structure of a protein essential to cell wall assembly in MRSA (and other bacteria that infect humans) called MraY, and by working with the Centre for Drug Research and Development (CDRD), we aim to identify and test chemical compounds that could act as new treatment options for antibiotic resistant bacterial infections.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Workman, Sean D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~